Oncolytic Virus Immunotherapy

by Antonio Marchini, Carolina S. Ilkow, Alan Melcher
Published 2021-07-01

The Rubella virus capsid is an anti-apoptotic protein that attenuates the pore-forming ability of Bax.

by Carolina S Ilkow, Ing Swie Goping, Tom C Hobman
Published 2011-02-01

From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer.

by Carolina S Ilkow, Stephanie L Swift, John C Bell, Jean-Simon Diallo
Published 2014-01-01

Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy

by Carole Achard, Abera Surendran, Marie-Eve Wedge, Guy Ungerechts, John Bell, Carolina S. Ilkow
Published 2018-05-01

Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis

by Taha Azad, Reza Rezaei, Abera Surendran, Ragunath Singaravelu, Stephen Boulton, Jaahnavi Dave, John C. Bell, Carolina S. Ilkow
Published 2020-07-01

Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference

by Donald Bastin, Amelia S. Aitken, Adrian Pelin, Larissa A. Pikor, Mathieu J. F. Crupi, Michael S. Huh, Marie-Claude Bourgeois-Daigneault, John C. Bell, Carolina S. Ilkow
Published 2018-06-01

A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion

by Taha Azad, Reza Rezaei, Ragunath Singaravelu, Taylor R. Jamieson, Mathieu J. F. Crupi, Abera Surendran, Joanna Poutou, Parisa Taklifi, Juthaporn Cowan, Donald William Cameron, Carolina S. Ilkow
Published 2021-03-01

Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization

by Taha Azad, Ragunath Singaravelu, Mathieu J.F. Crupi, Taylor Jamieson, Jaahnavi Dave, Emily E.F. Brown, Reza Rezaei, Zaid Taha, Stephen Boulton, Nikolas T. Martin, Abera Surendran, Joanna Poutou, Mina Ghahremani, Kazem Nouri, Jack T. Whelan, Jessie Duong, Sarah Tucker, Jean-Simon Diallo, John C. Bell, Carolina S. Ilkow
Published 2020-08-01

Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies

by Laura Evgin, Carolina S Ilkow, Marie-Claude Bourgeois-Daigneault, Christiano Tanese de Souza, Lawton Stubbert, Michael S Huh, Victoria A Jennings, Monique Marguerie, Sergio A Acuna, Brian A Keller, Charles Lefebvre, Theresa Falls, Fabrice Le Boeuf, Rebecca A Auer, John D Lambris, J Andrea McCart, David F Stojdl, John C Bell
Published 2016-01-01

Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction

by Emily E. F. Brown, Reza Rezaei, Taylor R. Jamieson, Jaahnavi Dave, Nikolas T. Martin, Ragunath Singaravelu, Mathieu J. F. Crupi, Stephen Boulton, Sarah Tucker, Jessie Duong, Joanna Poutou, Adrian Pelin, Hamed Yasavoli-Sharahi, Zaid Taha, Rozanne Arulanandam, Abera Surendran, Mina Ghahremani, Bradley Austin, Chantal Matar, Jean-Simon Diallo, John C. Bell, Carolina S. Ilkow, Taha Azad
Published 2021-02-01